Treatment of Topical Ketorolac Gel in Acute Gouty Flare

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Acute Gouty ArthritisAcute PainGout Flare
Interventions
DRUG

Ketorolac Tromethamine 15 MG/ML

Single intravenous administration of Ketorolac Tromethamine injection in Cohort 1 on day 1

DRUG

Ketorolac Tromethamine

Three doses of topical ketorolac tromethamine over the course of 1 day, 6 hours apart for each of 3 subsequent treatment periods in cohort 1 Three doses of Ketorolac Tromethamine, 6 hours apart, over the course of 5 days in cohorts 2 and 3

Trial Locations (2)

2148

Paratus Clinical,, Blacktown

6009

Linear Clinical Research Ltd, Nedlands

Sponsors
All Listed Sponsors
lead

Novilla Pharmaceuticals

INDUSTRY

NCT06273813 - Treatment of Topical Ketorolac Gel in Acute Gouty Flare | Biotech Hunter | Biotech Hunter